Innovation Medical Management Co., Ltd.
SZSE:002173.SZ
7.92 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 805.586 | 709.698 | 711.516 | 724.243 | 872.197 | 1,058.891 | 905.142 | 762.788 | 137.042 | 183.311 | 299.152 | 369.009 | 336.884 | 292.266 | 284.172 | 344.08 | 291.983 | 238.639 | 192.189 | 151.417 |
| Cost of Revenue
| 713.377 | 679.11 | 665.352 | 696.408 | 803.097 | 667.422 | 544.812 | 467.568 | 91.016 | 112.303 | 178.473 | 235.376 | 224.25 | 201.106 | 216.079 | 240.68 | 202.977 | 163.955 | 149.487 | 116.357 |
| Gross Profit
| 92.209 | 30.588 | 46.163 | 27.835 | 69.101 | 391.469 | 360.331 | 295.22 | 46.026 | 71.007 | 120.679 | 133.633 | 112.634 | 91.161 | 68.093 | 103.401 | 89.005 | 74.685 | 42.702 | 35.06 |
| Gross Profit Ratio
| 0.114 | 0.043 | 0.065 | 0.038 | 0.079 | 0.37 | 0.398 | 0.387 | 0.336 | 0.387 | 0.403 | 0.362 | 0.334 | 0.312 | 0.24 | 0.301 | 0.305 | 0.313 | 0.222 | 0.232 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 3.011 | 2.628 | 1.933 | 3.332 | 3.48 | 3.748 | 3.83 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 29.97 | 26.706 | 29.07 | 35.522 | 45.545 | 29.937 | 23.158 | 27.063 | 45.19 | 12.101 | 10.686 | 8.318 | 25.301 | 18.306 | 19.746 | 18.264 | 15.455 | 11.574 | 4.401 | 3.481 |
| Selling & Marketing Expenses
| 10.297 | 12.082 | 13.453 | 8.211 | 11.108 | 18.44 | 11.504 | 12.896 | 16.059 | 19.621 | 19.658 | 16.439 | 13.071 | 10.842 | 11.1 | 5.105 | 4.105 | 2.879 | 2.207 | 1.473 |
| SG&A
| 40.267 | 38.788 | 42.523 | 43.734 | 56.653 | 48.377 | 34.662 | 39.959 | 61.249 | 31.722 | 30.344 | 24.757 | 38.372 | 29.148 | 30.846 | 23.37 | 19.56 | 14.454 | 6.608 | 4.953 |
| Other Expenses
| -9.325 | 83.733 | 83.017 | 85.642 | 93.96 | -25.525 | -26.378 | -5.953 | -0.003 | 2.241 | 5.259 | -1.328 | 1.479 | 0.998 | 1.143 | -0.796 | 2.098 | 1.539 | 0.584 | 0.811 |
| Operating Expenses
| 126.433 | 122.521 | 125.54 | 129.376 | 150.613 | 142.69 | 118.905 | 105.425 | 85.724 | 59.751 | 56.635 | 54.257 | 44.671 | 32.844 | 34.637 | 26.925 | 23.936 | 17.252 | 9.503 | 6.494 |
| Operating Income
| -25.64 | -71.595 | -107.161 | -101.541 | -81.512 | 122.898 | 236.333 | 165.994 | -63.944 | -11.464 | 25.755 | 44.686 | 37.202 | 36.943 | 16.429 | 55.26 | 50.942 | 39.347 | 23.602 | 26.148 |
| Operating Income Ratio
| -0.032 | -0.101 | -0.151 | -0.14 | -0.093 | 0.116 | 0.261 | 0.218 | -0.467 | -0.063 | 0.086 | 0.121 | 0.11 | 0.126 | 0.058 | 0.161 | 0.174 | 0.165 | 0.123 | 0.173 |
| Total Other Income Expenses Net
| -9.325 | -3.686 | 2.317 | -183.41 | -1,068.916 | -151.406 | -31.471 | -29.883 | -24.538 | -20.521 | -33.05 | -36.034 | -29.289 | -20.376 | -15.887 | -22.012 | -12.029 | -16.547 | -9.065 | -1.606 |
| Income Before Tax
| -34.965 | -75.282 | -104.844 | -284.951 | -1,150.428 | 97.373 | 209.955 | 159.912 | -64.235 | -9.264 | 30.994 | 43.342 | 38.675 | 37.941 | 17.569 | 54.464 | 53.04 | 40.886 | 24.134 | 26.96 |
| Income Before Tax Ratio
| -0.043 | -0.106 | -0.147 | -0.393 | -1.319 | 0.092 | 0.232 | 0.21 | -0.469 | -0.051 | 0.104 | 0.117 | 0.115 | 0.13 | 0.062 | 0.158 | 0.182 | 0.171 | 0.126 | 0.178 |
| Income Tax Expense
| -0.677 | -1.412 | 0.274 | 29.453 | -0.646 | 67.43 | 69.163 | 45.135 | 1.102 | 1.577 | 6.332 | 4.75 | 6.54 | 6.886 | 4.896 | 11.551 | 13.065 | 10.595 | 5.725 | 6.17 |
| Net Income
| -34.288 | -73.87 | -105.117 | -314.404 | -1,149.782 | 29.677 | 140.743 | 114.713 | -65.338 | -10.842 | 23.712 | 38.174 | 30.037 | 28.764 | 11.784 | 37.359 | 35.429 | 26.221 | 15.417 | 17.183 |
| Net Income Ratio
| -0.043 | -0.104 | -0.148 | -0.434 | -1.318 | 0.028 | 0.155 | 0.15 | -0.477 | -0.059 | 0.079 | 0.103 | 0.089 | 0.098 | 0.041 | 0.109 | 0.121 | 0.11 | 0.08 | 0.113 |
| EPS
| -0.077 | -0.17 | -0.23 | -0.69 | -2.53 | 0.07 | 0.31 | 0.26 | -0.32 | -0.05 | 0.12 | 0.19 | 0.15 | 0.14 | 0.06 | 0.19 | 0.22 | 0.17 | 0.1 | 0.11 |
| EPS Diluted
| -0.077 | -0.17 | -0.23 | -0.69 | -2.53 | 0.07 | 0.31 | 0.26 | -0.32 | -0.05 | 0.12 | 0.19 | 0.15 | 0.14 | 0.06 | 0.19 | 0.22 | 0.17 | 0.1 | 0.11 |
| EBITDA
| 77.539 | 38.669 | 10.365 | -38.762 | -37.685 | 305.5 | 347.103 | 285.946 | -24.208 | 29.608 | 69.143 | 82.906 | 71.21 | 61.601 | 40.408 | 80.897 | 69.157 | 59.603 | 34.601 | 30.113 |
| EBITDA Ratio
| 0.096 | 0.054 | 0.015 | -0.054 | -0.043 | 0.289 | 0.383 | 0.375 | -0.177 | 0.162 | 0.231 | 0.225 | 0.211 | 0.211 | 0.142 | 0.235 | 0.237 | 0.25 | 0.18 | 0.199 |